Embryo genetic analysis is the examination of the chromosomal makeup of embryos created through IVF.

What Is IVF with Genetic Testing?

Let's briefly talk about genes and chromosomes: genes and chromosomes are the building blocks of human biology. Genes are segments of DNA molecules that code for specific traits of an organism. They are found in every human cell and are responsible for passing on inherited traits. The human body carries 46 chromosomes (23 pairs) in its cells. These chromosomes are located within chromatin, the coiled form of DNA molecules. Apart from the two sex chromosomes (X and Y), every human cell has 22 pairs of autosomal chromosomes. Embryo genetic testing is the examination of the chromosome structure, chromosome number, and genes of embryos.

Inherited diseases can be passed on to children because of the parents' genetic predispositions. However, thanks to modern medical methods, technologies such as genetic screening in IVF and genetic testing during pregnancy have made it possible to have healthy children. Parents with a family history of genetic disease in particular should be careful, as they may pass these conditions on to their children.

Illustration of a developing embryo inside a ring of light, explaining what IVF with genetic diagnosis means

For this reason, it is important for at-risk individuals who are considering having children to receive genetic counseling and, if necessary, undergo genetic testing. This approach helps prevent genetic diseases and, by contributing to healthy family planning, can improve the health and happiness of families.

What Is Embryo Genetic Testing?

Embryo genetic testing, known as Preimplantation Genetic Diagnosis (PGT, also called PGD) and Preimplantation Genetic Screening (PGS), is a method used to evaluate the genetic health of embryos during the IVF process. It is performed to detect genetic abnormalities in an embryo created by combining sperm and egg before the embryo is transferred. In this way, embryo genetic diagnosis testing makes it possible to select healthy embryos.

In the genetic examination of IVF embryos, a biopsy of 5–10 cells is taken from sufficiently mature embryos that have reached day 5 or 6 of the IVF treatment process, and genetic testing is performed. These biopsies do not harm the embryo. This procedure is called embryo genetic analysis.

Genetic testing of embryos prevents genetic disorders in the prospective mother and father from being passed on to the baby.

Embryo genetic testing can be used to detect a variety of genetic disorders. These include chromosomal abnormalities, carrier status for genetic diseases, single-gene disorders, and specific gene mutations.

PGS (Preimplantation Genetic Screening) is performed to detect abnormalities in chromosome number (aneuploidy) when there is no known genetic problem in the prospective mother and father.

What Does a Positive Genetic Test Result Mean?

A positive genetic test result usually indicates an abnormality in one or more of the genetic features examined in the test, or the presence of a risk for a specific genetic disease. A positive result may indicate that the person has an increased risk of having a particular disease or genetic condition, or that they may be a carrier. However, a positive result is usually not a diagnosis; rather, it indicates the presence of a particular risk or carrier status.

A positive genetic test result may require the person and their healthcare providers to take certain measures. For example, if a couple's embryo genetic test comes back positive, the chance of success in IVF treatment can be increased by excluding embryos that carry a particular genetic disease risk or by selecting healthy embryos. Similarly, if an expectant mother receives a positive result on a genetic test performed during pregnancy, more careful planning can be made regarding the baby's health and postnatal care.

However, a positive genetic test result is not always cause for concern, and it can have different implications for each individual. For this reason, it is important for people who receive a positive genetic test result to have a detailed discussion with a genetic counselor or specialist. Specialists can provide the guidance needed to explain what a positive result means, assess possible risks, and recommend appropriate treatment or preventive measures.

What Is Genetic Testing in Pregnancy?

Genetic tests during pregnancy are tests performed during pregnancy to evaluate the genetic health of the baby. These tests examine the genetic makeup of the fetus with the aim of identifying inherited diseases or genetic abnormalities. Some examples of genetic tests in pregnancy are the double test, triple test, quad test, and fetal DNA test. These are screening tests. A diagnosis can be made with diagnostic tests such as CVS (chorionic villus sampling) or amniocentesis, which allow direct genetic examination of the cells. When there is a risk of genetic disease in pregnancy, the best approach is genetic testing of embryos before pregnancy. Transferring a genetically healthy embryo greatly reduces the likelihood of giving birth to a child with a genetic problem.

How Is IVF Genetic Screening Performed?

Embryo genetic testing consists of preimplantation genetic diagnosis (PGD, PGT) or preimplantation genetic screening (PGS). The process usually includes the following steps:

IVF Process: First, eggs are collected from the prospective mother and sperm from the prospective father, and fertilization takes place in the laboratory.

Embryo Development: The fertilized eggs are monitored in the laboratory for 5–6 days as they develop into embryos.

Embryo Biopsy: At a certain stage of embryo development, one or more cells are removed and biopsied for genetic analysis. In the past, embryo biopsies were taken on day 3. However, day-3 embryos have only 6–8 cells, and removing one or two cells for biopsy could harm the embryo. That is why day-5 embryo biopsy is preferred today. A day-5 embryo (blastocyst) consists of 2 layers. The inner layer (inner cell mass) is the layer from which the baby develops, while the outer layer is the trophectoderm, the layer from which the placenta develops. Embryo biopsy is taken from the outer layer, and the biopsy does not damage the inner layer. A biopsy of 5–10 cells is taken from the blastocyst under a microscope and sent to the genetics laboratory for testing. IVF embryo biopsy does not harm the embryo.

Genetic Analysis: Genetic analysis is performed on the cells obtained from the embryo biopsy. This analysis may be done to examine the embryo's chromosomal makeup or to determine the presence of, or carrier status for, specific genetic diseases. Methods used may include polymerase chain reaction (PCR), array karyotyping, or more advanced technologies such as next-generation sequencing (NGS).

Embryo Freezing: The embryos are frozen while the genetic test results are pending. It is not possible for embryos to stay fresh and viable for the approximately 2 weeks spent waiting for genetic test results, so the embryos are frozen in the meantime.

Selection of Healthy Embryos: Based on the genetic analysis results, healthy embryos are identified and selected for transfer.

Embryo Transfer: Genetically healthy embryos are transferred into the prospective mother's uterus.

PGT is used to increase the chance of a successful IVF outcome for couples at genetic risk. However, it is important to remember that PGT is not always 100% accurate and is not guaranteed to detect all genetic disorders.

What Are the Methods of IVF Embryo Genetic Analysis?

For the diagnosis of single-gene disorders, the PCR (polymerase chain reaction) technique is used. A few of the embryo's cells are removed by biopsy, and the genetic material is prepared in special solutions for testing. The targeted gene region is amplified and its sequence is determined, which shows whether or not the embryo carries the disease.

To diagnose numerical and structural chromosomal abnormalities, the fluorescence in situ hybridization (FISH) technique is used. An embryo cell is removed by biopsy, and in the laboratory, specific chromosome regions are identified using markers called probes. In this way, healthy embryos can be distinguished from unhealthy ones.

NGS is the abbreviation for "next-generation sequencing." NGS refers to the process of sequencing DNA or RNA. This technology makes it possible to sequence many DNA or RNA molecules simultaneously and quickly. NGS is widely used in many fields, particularly in genetic research and in medical diagnosis and treatment.

How does NGS differ from conventional PGT? NGS is a technology used to carry out the genetic analysis of conventional PGT. While conventional PGT usually examines a limited number of gene regions or chromosomes, NGS allows many genes to be analyzed simultaneously and in detail. This provides more comprehensive genetic screening and a better assessment of the genetic risks an embryo carries. For this reason, NGS-based PGT provides a more comprehensive genetic analysis than conventional PGT and allows more precise results to be obtained.

Who Should Have IVF Genetic Screening?

Who is embryo genetic testing for? Embryo genetic testing is performed during the in vitro fertilization (IVF) process, but it is not a routinely recommended procedure. This screening is carried out to determine whether embryos carry genetic disorders. Embryo genetic screening should be performed in the following situations:

Hands holding an ultrasound photo in front of a pregnant belly, explaining who needs genetic screening in IVF

  • History of Recurrent Miscarriage (Recurrent Pregnancy Loss): In couples who have had recurrent miscarriages, embryo genetic screening can be performed to identify the underlying genetic factors.
  • Advanced Female Age (Advanced Maternal Age): Women over the age of 37 in particular may experience declining egg quality due to age and an increase in embryo chromosomal abnormalities. Because the risk of genetic abnormalities in embryos is higher in older women, embryo genetic screening is recommended. Embryos with abnormal genetics are among the most important causes of IVF failure.
  • Recurrent Failed IVF Attempts: After repeated unsuccessful IVF attempts, screening can be performed to evaluate the genetic health of the embryos.
  • Carrier Screening: This can be performed to determine whether the couple carries specific genetic diseases and to evaluate the effects of these diseases on the embryo. When specific genetic disorders are present in the prospective mother or father (such as being a translocation carrier), genetic analysis should be performed on the embryos.
  • Male factor infertility
  • Couples who had a child with a genetic disease in a previous pregnancy
  • A tissue-matched (HLA) sibling, for example when a bone marrow transplant is needed
  • Couples at risk of a single-gene disorder
  • Genetic screening is recommended for couples in consanguineous marriages (married to a blood relative).

Embryo genetic screening is performed as part of the genetic counseling process and can help couples make informed decisions about their embryos. This screening is used to increase the chance of a healthy pregnancy and a healthy birth, and you should be guided by a physician who is experienced in this field.

What Are the Advantages of Embryo Genetic Testing?

Today, many couples turn to IVF to make their dream of having a child come true. However, in the IVF process, it is important not only to achieve a pregnancy but also to have a healthy pregnancy. This is where genetic analysis can help couples get off to a healthy start.

Genetic analysis is a method used to evaluate the genetic health of embryos and to determine the presence of genetic diseases. By examining the genetic makeup of embryos before embryo transfer, this analysis makes it possible to select healthy embryos.

The benefits of embryo genetic testing can be listed as follows:

  • Early Detection of Genetic Disorders: Embryo genetic testing examines the genetic makeup of embryos and detects potential genetic disorders early. This prevents potentially affected embryos from being transferred and increases the chance of a healthy pregnancy.
  • Reduces the Risk of Miscarriage: Genetic problems in the embryo are the cause of most recurrent miscarriages and recurrent IVF failures. Embryo genetic testing can be used to identify the genetic factors underlying recurrent miscarriages. This increases the prospective mother's chance of achieving a healthy pregnancy.
  • Increases the Chance of a Live Birth: After the transfer of a genetically healthy embryo, both the rate at which the embryo implants in the mother's uterus and the IVF live birth rate increase.
  • Prevention of Genetic Diseases: By determining the presence of, or carrier status for, specific genetic diseases, embryo genetic testing can increase a couple's chance of having a healthy baby. In this way, the risk of genetic disease in the family can be reduced. In addition, if a specific genetic problem has been diagnosed in the family's previous children, the embryos created through IVF can be tested, and a healthy baby can be born after the transfer of a genetically healthy embryo.
  • Improved Pregnancy Outcomes: Embryo genetic testing procedures can improve pregnancy outcomes by enabling the selection of healthy embryos. This increases the likelihood of a healthy pregnancy and a healthy birth. Single embryo transfer also lowers the risk of twin or triplet pregnancy.
  • Protecting the Health of Mother and Baby: Transferring healthy embryos protects the health of both mother and baby. Selecting genetically healthy embryos can reduce the risk of complications at birth and provide psychological relief for the family.
  • Reduced Psychological Burden of IVF: With repeated failed IVF attempts, the prospective mother and father are also affected psychologically. When a genetically normal embryo is transferred after embryo genetic testing, the chance of IVF success and the IVF live birth rate are high. As a result, the chance of getting pregnancy news on the first IVF attempt and the IVF healthy live birth rate are high.

These advantages allow embryo genetic testing procedures to improve the happiness and health of families by increasing couples' chances of achieving a healthy pregnancy.

What Are the Problems with Embryo Genetic Testing?

  • Day-3 embryo biopsy, as was done in the past, is no longer recommended. That is why we wait for embryos to reach day 5. Sometimes embryos may not reach day 5, and in that case, IVF embryo biopsy is not performed.
  • The chance of pregnancy after the transfer of a genetically normal day-5 embryo is not 100%. If pregnancy does not occur after the transfer of a genetically normal embryo, the transfer of another genetically normal embryo is recommended.
  • Sometimes all of the genetically tested embryos may turn out to be abnormal, and the couple may need to undergo IVF treatment again, with another egg retrieval to create new embryos.
  • Transferring a genetically normal embryo does not eliminate the risk of pregnancy complications. For this reason, prospective mothers who may have a high-risk pregnancy should be identified before embryo transfer, and the transfer should be planned after they have received treatment.

What Is a Mosaic Embryo?

Mosaicism is the presence of different genetic cell lines in one individual. Studies have reported many healthy live births after the transfer of mosaic embryos, and this body of data is growing every day.

Can a genetically abnormal embryo implant after transfer? The result of an embryo genetic analysis may come back as mosaic. Healthy births from such embryos are possible through different mechanisms.

  • First, mosaic embryos can correct themselves and eliminate the abnormal cells. If this fails, however, a true mosaic fetus or genetic disorders may result.
  • Second, a mosaic result is an intermediate finding observed in the biopsy sample and may not fully reflect the true genetic status.
  • Third, a single biopsy result may not fully represent the true genetic makeup of the embryo.

Mosaic embryos are classified according to the percentage of abnormal cells and transferred accordingly, but this classification is not evidence-based. In general, mosaic embryo transfer is associated with a lower live birth rate and a higher miscarriage rate compared with euploid transfers. However, recent evidence shows that embryos with mosaic results do not rule out live births. For this reason, it is argued that these embryos should be transferred rather than discarded. Mosaicism is a major challenge of PGT-A, and further challenges may arise in the field of reproductive genetics in the future.

What Is a Genetic Screening Test?

Embryo genetic testing is performed for screening (PGS, PGT-A) or diagnostic (PGT, PGT-M) purposes. Embryo genetic screening tests (PGS, preimplantation genetic screening, PGT-M) are recommended for examining embryos in cases of recurrent miscarriage, recurrent IVF failure, or advanced maternal age, because the likelihood of chromosomal abnormalities is higher in these situations.

In the past, genetic tests were performed only for certain chromosomes using the FISH method; today, using a comprehensive chromosomal screening technique (aCGH), all of the tested embryo's chromosomes and any abnormalities in them can be detected.

Embryo genetic diagnostic testing (PGD, preimplantation genetic diagnosis, PGT, PGT-A), on the other hand, is used to investigate whether a known genetic abnormality in the prospective mother or father, or a condition they carry, is present in the embryo. Candidates for PGT to investigate single-gene disorders are couples with chromosomal abnormalities (translocations, inversions); couples who are carriers of known mutations such as cystic fibrosis or Mediterranean anemia (thalassemia); couples with a known family history of genetic disease; and couples who have had a previous child with a known genetic disease. PGT is also commonly used to identify embryos with a compatible tissue type (HLA typing) so that a sibling with a blood disorder can be treated.

Genetic Disease Carrier Testing: This test is performed for couples who have a child with a genetic disease, family members who are carriers of a genetic disease, couples in consanguineous marriages, which are especially common in our country, and couples belonging to certain ethnic groups. This test provides an evaluation of more than 200 genetic diseases and approximately 1,600 mutations for which a person may be a carrier.

If a woman or man has balanced chromosomal abnormalities, even if they appear completely healthy, these can cause autism, intellectual disability, developmental delay, abnormal physical features, and many other anomalies in their children. In this case, up to 80% of the embryos created through IVF may be abnormal or carriers.

Chromosome karyotype analysis is performed on blood samples from the woman and the man.

The newly developed chromosomal microarray test detects small genomic imbalances that conventional karyotyping cannot detect and provides more diagnostic information.

How Is a Genetic Evaluation Performed?

A genetic evaluation is performed to examine a person's genetic makeup and identify potential genetic diseases. In the IVF process, a genetic evaluation usually includes the following steps:

  • Initial Assessment and Family History: During the initial assessment of couples who come to the Ataşehir IVF clinic, the couple's family history and genetic background are reviewed. At this stage, the aim is to identify any genetic diseases in previous pregnancies or in the family.
  • Genetic Counseling: Before starting the IVF process, couples are offered genetic counseling. This counseling informs couples about genetic risks, explains the advantages and disadvantages of genetic testing, and provides information about the possible genetic risks they may encounter during treatment.
  • Genetic Tests: In some cases, genetic tests may be recommended for couples. These tests are performed to identify specific genetic diseases that the couple carries or is at risk for. A blood sample or other tissue samples are usually used for testing.
  • Embryo Genetic Testing (PGT): For some couples, embryo genetic testing may be performed during the IVF process. Also known as preimplantation genetic diagnosis (PGT), these tests are used to evaluate the genetic health of embryos. They involve embryo biopsy and genetic analysis.
  • Evaluation of Genetic Results and Treatment Plan: Genetic test results are analyzed and interpreted by specialists. A treatment plan is then created and personalized based on the couple's genetic risks and genetic test results.

Genetic evaluation during the IVF process is important for increasing couples' chances of achieving a healthy pregnancy and reducing the risk of genetic disease. Expert genetic counseling and the right genetic tests are critical in helping couples make the right decisions during this process.

Illustration of a baby curled inside a glowing sac, discussing whether genetic testing harms the embryo

Does IVF Genetic Testing Harm the Embryo?

Preimplantation genetic diagnosis (PGT) and screening tests are generally considered safe. Day-5 and day-6 embryos contain more than 100 cells. In experienced hands, the biopsy does not harm the embryo. However, as with any medical procedure, it is important to note that there are potential risks. Here are some important points:

Embryo Biopsy: During PGT, one or more cells may need to be removed from the embryo. This biopsy procedure can affect the embryo's health and could potentially cause harm. However, when it is performed by an experienced specialist using appropriate techniques, this risk is minimal.

Laboratory Procedures: After embryo biopsy, the cells removed are processed in the laboratory for genetic analysis. These procedures could potentially affect the embryo. However, when they are carried out with modern laboratory technology and by experienced laboratory staff, the risk of harm is minimal.

Implantation Failure: There is concern that embryo biopsy and genetic analysis may negatively affect the embryo's development and lead to implantation failure. However, research shows that these concerns should largely be downplayed. When performed properly, embryo genetic testing has been found not to reduce pregnancy rates or affect healthy birth rates.

Rare Complications: In rare cases, complications may occur during embryo biopsy or laboratory procedures. Situations such as infection, bleeding, or damage to the embryo may occur. However, when the procedure is performed by an experienced healthcare team, the risk of such complications is minimal.

Overall, when PGT and screening tests are performed correctly and managed by an experienced team, they carry minimal risk of harm to the embryo. Patients should be informed in detail about the potential risks before starting treatment and should talk to their doctor when needed.

How Much Does Genetic Screening Cost?

Embryo genetic testing fees can vary depending on many factors and differ from clinic to clinic. In general, however, the cost of embryo genetic testing can be high. The cost varies depending on the technology used, the scope of the test, the laboratory's experience, and the country's healthcare system.

The fee for embryo genetic testing usually includes the embryo biopsy, genetic analyses, laboratory work, counseling services, and other related expenses. In addition, some clinics may offer additional services or optional tests, which can affect the cost.

Advanced embryo genetic tests such as preimplantation genetic diagnosis (PGT) in particular may cost more. These tests are used to evaluate the genetic health of embryos in greater detail and usually require more advanced technology and expertise.

As a clinic, patient satisfaction and health are our priorities. As Ataşehir OB-GYN Prof. Dr.  Çiğdem Yayla Abide and her team, we are here to protect your health and your baby's health with a patient-centered approach, offering the most suitable and effective solutions. You can contact us to learn more about the prices of our tests and our payment options.

Frequently Asked Questions

What Is the Purpose of Embryo Genetic Testing?

Abnormalities in embryo genetics are the most common cause of IVF treatment failure. Genetic testing in IVF is a technique performed as part of the in vitro fertilization (IVF) process. During this process, the genetic health of the embryos is evaluated, with the aim of detecting genetic diseases or identifying genetic carrier status.

What Does Embryo Genetic Screening Look For?

Embryo genetic screening examines the structure, number, and shape of the embryo's chromosomes to detect aneuploidy (Down syndrome, Edwards syndrome, etc.), and analyzes the genes on the chromosomes to detect single-gene disorders (SMA, cystic fibrosis, thalassemia, etc.), inherited conditions such as familial Mediterranean fever, and certain cancers linked to specific genes, such as breast cancer.

How Many Days Does Embryo Genetic Testing Take?

This is one of the most frequently asked questions: "When will the embryo genetic test results be ready?" Embryo genetic test (PGS, PGT) results are available within one week to 10 days. The timing depends on the genetic abnormality being examined with embryo genetic testing; for some inherited diseases, it takes longer.

What Is Embryo Freezing After Genetic Screening?

In IVF treatment with genetic testing, biopsies for genetic analysis are taken from embryos that reach day 5. The biopsies are sent to the genetics department for testing. While the IVF genetic test results are pending, the biopsied embryos are frozen and stored for future transfer. Once the embryo genetic analysis results are available, the genetically healthy embryos are thawed and transferred. With the rapid freezing method we call vitrification, embryos can be stored for years without deterioration in our partner laboratory.

Why Doesn't a Genetically Normal Embryo Implant?

After the transfer of a genetically normal embryo, the pregnancy rate rises to around 80%. If pregnancy does not occur after the transfer of a genetically normal embryo, the following should be reviewed: Hormonal problems (thyroid disease, elevated prolactin) and systemic conditions such as diabetes, Problems such as blocked tubes or adhesions in the uterus, Poor embryo quality. A biopsy is not recommended for every embryo. An experienced physician and embryologist should guide you on which embryos should be biopsied.